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Abstract
Purpose: Our objective was to assess the impact of a heterogeneity correction tothe calculated dose for left breast cancer gated radiotherapy. Methods: Tenpatients with left breast cancer were studied. For each patient 2 treatment planswere generated. In plan 1 the dose was calculated using a Pencil Beam Convolution(PBC) algorithm. In plan 2 the dose was calculated using the Modified Batho's (MB)density correction method. To compare the two plans a dosimetric analysis wascarried out including monitor units (MU), isodose curves, cumulative anddifferential dose volume histograms (cDVH, dDVH), coverage index, conformityindex for target volume and the two dimensional (2D) gamma index (γ). Wilcoxonsigned rank and Spearmen's tests were used to calculate p-values and correlationcoefficients (r), respectively. Results: MB method reduced the MU by on average1.12 ± 5.33%. The analysis of cDVH showed that the MB method calculatedsignificantly higher doses for target volumes, lung and heart, p < 0.05. The datademonstrated a strong correlation between the dosimetric parameters derivedfrom plan 1 and plan 2 with r > 0.9. The 2D γ analysis showed that the differencebetween plan 1 and plan 2 could reach ± 10%. The γ evaluation showed a highimpact of density correction for left breast cancer with gating technique.
Conclusion: This study confirms that using the MB method integrated with a PBCalgorithm, the calculated dose will be increased to target volumes, lung and heart.Even more so since gating usually tends to decrease average lung density by about39% by treating during an arrested inspiration phase. Thus, attention should bepaid when changing from PBC to newer algorithms with gating techniques, sincethe probability of cardiac mortality and lung toxicity are correlated to absorbeddose.
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1. IntroductionRecent advances in radiotherapy have introducedseveral irradiation techniques for breast cancer. Severalstudies have demonstrated that respiratory gatingimproves the accuracy of dose delivery to the targetvolume in breast cancer radiotherapy by reducing dosesto organs at risk (OAR), i.e the heart and lungs.1,2 Duringthe treatment, the dose received by the target volume(TV) should be close to the prescribed dose. The formeris currently predicted by the treatment planning
software based on dose calculation models. Certainorgans i.e. lung and heart have tolerance dose limits thatshould be respected and an accurate dose calculation isnecessary for this. Presently, there are variousalgorithms and methods to take account of theheterogeneity correction of tissues. Numerous reviewsin the literature have categorized the heterogeneitycorrection methods according to various criteria.Recently, Chaikh et al. classified the algorithms into
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three types according to whether they take into account,or not, the density correction and inclusion or exclusionof electron transport.3
 Type (a): change in lateral transport of electronsis not modelled, e.g. density correction methodsintegrated into the pencil beam convolutionalgorithm (PBC) in the Eclipse® treatmentplanning system (TPS) (Varian Medical Systems,Palo Alto, CA), such as Modified Batho's (MB)density correction method.
 Type (b): approximate the transport of electronssuch as the anisotropic analytical algorithm (AAA)and collapsed cone convolution (CCC)implemented respectively in the Eclipse andPinnacle® (Philips Radiation Oncology Systems,Fitchburg, WI) TPS.
 Type (c): which solves the linear Boltzmanntransport equation: Acuros XB (Varian MedicalSystems, Inc., Palo Alto, CA).Type (a) and type (b) algorithms calculate absorbeddose to water. In contrast, Acuros XB a type (c),calculates dose to a medium, which can be convertedinto the dose to water for treatment plan evaluation.When the beam goes through relatively low-density lungtissue, the heterogeneity correction should be done withan accurate algorithm. Recent studies have discussed theimpact of low-density organs on the coverage ofadjacent target volumes, as in breast cancer treatment.They showed that the dose calculation algorithm has asignificant impact on dosimetry and radiobiologicalmodel parameters.4-8 However, we have little knowledgeabout the impact of heterogeneity corrections on targetvolume and organs at risk using the gating technique forbreast cancer. In the present study, we will assess whatthe impact would be of switching from PBC to MB ondoses when using gating technique radiotherapy.
2. Methods and Materials
2.1 Clinical cases and treatment planningThis study is based on ten patients with left breastcancer. These cases were chosen to cover the full rangeof the different types of radiotherapy, namely: breastalone, breast with boost, breast with internal mammarychain (IMC) or with IMC and the supra-clavicular area. Acomputed tomography (CT-scan) was done using therespiratory gating technique. Then the images wereloaded into the TPS.The virtual simulation for each patient was generated bya digitally reconstructed radiograph (DRR) and beam'seye view (BEV) information. In this way a treatmentfield was superimposed on the DRR to assess targetlocalization. The target volumes including the securitymargins and the organs at risk were delineated by theradiation oncologist. The treatment was performed withfour tangential beams according to the technique
currently used in our department: 2 tangential beams of6 Megavoltage (MV) and 2 tangential beams of 18 MV.The combination of four beams of two energies withdifferent beam ponderation and field size, with orwithout a wedge, has been introduced to optimize thedose homogeneities more accurately than with just apair of tangential beams with wedge filters. Theconventional radiation course varied from 46.91 to 50.6Gy in 23 - 25 daily fractions of 1.87 - 2.2 Gy on the wholebreast followed by the addition of a boost to the tumorbed. The boost consisted of doses varying from 11 to 15Gy in 5 - 23 daily fractions of 0.5 to 2.5 Gy.For each patient, two treatment plans were generated:in plan 1 the dose was calculated using the PBC whichwas taken as the reference dose, in plan 2 the dose wascalculated using the MB method in combination with thePBC algorithm. The PBC algorithm is a convolutionalgorithm based on pencil beam kernels. First, the dosedistribution in a homogeneous water equivalentmedium is calculated. Next, the tissue densities aretaken into account by multiplying the dose distributionby a correction factor. In the MB method, theinhomogeneity correction factor is calculated along thecentral axis.
2.2 Treatment plans evaluations
2.2.1 Monitor units (MU)A calculation of the average and standard deviation wasperformed for each field.
2.2.2 Isodose curvesThe 95% and 100% isodose curves encompassing theTV were compared.
2.2.3 Dose volume histogram (DVH)For each TV the minimum dose (Dmin), mean dose(Dmean), maximum dose (Dmax) and the calculateddose to 95% of the target volume (D95%) werecompared using cumulative cDVH. For lung and heartthe Dmin, Dmean and Dmax were compared. The dosehomogeneity inside the TV, lung and heart werecompared using a S-index associated with thedifferential dDVH 9:
TV
1j
2Dmean)(D(j)TV  indexS (1)where, D(j) is the relative dose in the lesion voxel j,Dmean is the average relative dose in the lesion and TVis the target volume in elementary voxels.For each patient, to compare plan 2 with plan 1, thecalculated doses in plan 1 were taken as the referencevalues. The difference in percentage was calculated as:ΔDose (%) = (DMB - DPBC ) × 100 / DMB (2)
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2.2.4 Quality indicesThe coverage index (CI) and conformity index for thetarget volume (CITV) proposed by the RadiationTherapy Oncology Group (RTOG) were compared usingthe following equations 10,11 :CI = (3)where, Imin is the minimal isodose surrounding thetarget and RI is the reference isodose.CITV = (4)where, PD is the prescribed dose and TV is the targetvolume.
2.2.5 Variation of lung density using a gating
techniqueThe CT images using either free breathing or the gatingtechnique were exported to TPS, then the averagehounsfield unit (HU) value was calculated for lung. Next,The HU was converted to relative electronic density (ρw)using the following equation 12 :HU= 1000.[(ρ/ ρw) -1.0]              (5)where, ρw is the density relative to water measured usingCT images.
Figure 1 shows an example of a HU calculation using theTPS for a volume of interest located in the lung.
2.2.6 Gamma indexThe impact of heterogeneity correction was analyzedusing the two dimensional (2D) gamma index (γ) bycomparing dose distributions from plan 1 and plan 2.13,
14,15 Our goal was to determine the volume ratioreceiving the same irradiation, in terms of γ whichcombines two criteria including the dose difference(ΔDose) in percentage and the distance-to -agreement(DTA) in millimeters. An ellipse is used to determine theacceptable region, and γ ≤ 1 represents fulfillment of thecriteria. The DICOM images for each patient wereexported from TPS to RIT-113® (Dosimetry SystemVersion 5.2, Radiological Imaging Technology, Inc., CO)
including the dose distributions. The dimensions were20 × 20 cm² with a resolution of 0.39 mm. The resultswere displayed using γ maps and dose pixel histograms(DPH). The γ maps show the pixels with γ values greaterthan unity that were outside of tolerance range. Thepixels with γ > 1 show either an under- or overestimateddosage associated with plan 2 compared to plan 1. Inorder to discriminate between an over- and anunder-estimated dose, a color-code was attributed to theΔDose. The DPH indicates the fraction of pixels with aspecific value of ΔDose. Using the γ criteria (3%, 3 mm)we considered that the plan 1 and plan 2 were similar if95% of pixels had γ ≤ 1.
2.2.7 Statistical analysisA Wilcoxon signed rank test was used to calculate the
p-value. A bilateral statistical test was realized with anerror α = 5%, corresponding to a 95% confidenceinterval. The Δdose is considered significant if p < 0.05.Data are presented as average ± standard deviation (SD).The statistical correlation between calculated dosesfrom plan 1 and plan 2 was evaluated using Spearmen’scorrelation coefficient.16 The correlation betweendensity difference (Δdensity) and Δdose was alsoevaluated.
3. Results
3.1 Monitor unitsThe MB reduced the MU by on average 1.12 ± 5.33%.The Wilcoxon test showed that there was no significantdifference between plan 1 and plan 2, p = 0.27 and thedata showed a strong correlation with r = 0.99.
3.2 Isodose curvesIn the transversal plans, we observed that both the 95%and 100% isodose curves encompassed the samefraction of the TV with the two techniques. The 40%isodose curve is closer to the heart and lung with MBthan with PBC. Figure 2 shows isodose curves in colorshading showing the dose distribution from plan 1 withPBC and plan 2 with MB.
Figure 1: Example of a HU calculation using the TPS for a volume of interest located in the lung.
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Figure 2: Dose distribution according to plan (A) with PBC and (B) with MB.
3.3 Dose volume histograms
3.3.1 cDVHFigure 3 shows the cDVH from plan 1 and plan 2. TheTables 1 and 2 show dosimetric and statistical resultsobtained for TV, lung and heart. In Table 1, it can be seenthat the Wilcoxon test indicated a very significantdifference between calculated doses with PBC and MB.
Spearman’s test indicated a strong correlation for Dmin,Dmean and D95%. In Table 2, it can be seen that MBcalculated higher doses for lung and heart with verysignificant differences, except for the lung’s Dmin. TheSpearman’s test indicated a strong correlation except forthe lung’s Dmax.
Figure 3: Cumulative dose volume histograms calculated using the PBC algorithm without heterogeneity correction for plan1, and the MB method with 1D heterogeneity correction for plan 2.
Table 1: Dose differences for dose volume histograms for target volumes.ΔDose % Dmin Dmean Dmax D95%Average ± SD 3.88 ± 6.3 2.55 ± 3.11 2.71 ± 3.45 2.27 ± 6.48r-value 0.99 0.97 0.77 0.9
p-value < 0.01 < 0.001 < 0.001 < 0.001
Table 2: Dose differences for dose volume histograms for organs at risk.ΔDose % Dmin Dmean DmaxLung Average ± SD 5.8 ± 12.4 7.6 ± 1.3 3.5 ±1.7r-value 0.93 0.99 0.52
p-value 0.37 < 0.01 < 0.01Heart Average ± SD 23 ± 8.5 11.41 ± 4.48 8.35 ± 4.29r-value 0.94 0.98 0.99
p-value < 0.01 < 0.01 < 0.01
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3.3.2 dDVHThe dose distribution inside the TV, lung and heart usingMB was slightly more heterogeneous than with PBC. Theaverage S-indexes for the target were 10.52 ± 10.11 and10.37 ± 10.04 for MB and PBC, respectively. Wilcoxonand Spearman’s tests showed no-significant differencesbut strong correlations with p = 0.46 and r =0.99. Forlung, the average S-indexes were 31.3 ± 4.19 and 29.28 ±4.04 for MB and PBC, respectively. For heart, the averageS-indexes were 1.89 ± 1.99 and 1.81 ± 2.01 respectively.Wilcoxon and Spearmen’s tests showed a significantdifference and strong correlation with p < 0.005 and r =0.99.
3.4 Quality indicesThe average CIs were 1.05 ± 0.58 and 0.98 ± 0.56 for MBand PBC, respectively, with p = 0.03 and r = 0.98. Theaverage CITVs were 0.67 ± 0.27 and 0.63 ± 0.29 for MBand PBC, respectively, with p = 0.20 and r = 0.81. Figure4 shows the indices values using a boxplotrepresentation. It can be seen that both plan 1 and 2have the same median values for CI and close values forCITV.
Figure 4: Boxplot for quality indices indicating theminimum, median and maximum values, as well as the 25thand 75th percentiles.
3.5 Variation of lung density using a gating
techniqueThe HU calculated for lung was -727.25 ± 42 and -835.25± 23.68 using free breathing and gating techniques,respectively. This leads to a decrease in lung densitywith the gating technique from 0.27 ± 0.04 to 0.16 ±0.02. The Wilcoxon test showed a very significantdecrease of density with p < 0.001. However, the data fordensity are highly variable from one patient to another,which explains why no correlation appears between thedensity and the associated breathing modality, freebreathing or gating, r = 0.36. This is due to basal tissuedensity and a morphologic effect resulting in the gatingtechnique being very different for each patient.
Figure 5: Correlation between Δdensity and Δdose fortarget volume in all patients.Lung inflation during an inspiration, with gatingincreases the lung volume, which will consequentlyincrease the distance between the TV and the heart.However, there was a poor correlation between densitydifferences (Δdensity) and Δdose, with r values rangingfrom r = 0.52 to 0.62. Figure 5 shows the correlationbetween density and dose for Dmin, Dmean and Dmaxfor the TV for all patients.
3.6 2D gammaThe average maximum and mean γ values were 2.82 ±0.65 and 0.23 ± 0.11, respectively. The tolerance limit of95% of pixels having γ ≤ 1 is not respected at all. Theaverage γ passing rate was 92.5 % ± 4.98 %. Figure 6shows an example of a 2D γ map in the axial plane. Thered and blue coloring indicate when the γ value > 1 andidentify overestimated dose (DMB > DPBC) orunderestimated dose (DMB < DPBC), respectively. Figure 7shows the DPH obtained from plan 1 and plan 2. It canbe seen that the tolerance limit of 95% of pixels having γ≤ 1 can be satisfied with a ΔDose = 7% and 3 mm. Thecorrelation test showed that there was a weakcorrelation between γ passing rates and dose difference.
Figure 6: An example of a 2D γ-map plotted in the axialplane (left panel) and CT-scan (right panel) correspondingto treatment for one patient with four tangential fields.
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Figure 7: DPH obtained with MB and PBC from plan 1 and plan 2 respectively.
4. DiscussionUsing the respiratory gating technique, we observed thatthe lung density was decreased by 38.7 ± 9.82%. Therange effect of lateral electrons is expected to be larger ifthe lung density is lower. The MB method integratedwith PBC does not model the lateral electron transport.This algorithm will overestimate the coverage of the TVand underestimate the low dose volumes in or near toOAR. In this study, the MU for the set of treatments wassubstantially shorter with MB than with PBC, p > 0.05.The cDVH and dDVH analysis for the TV showed that MBoverestimated the dose for the target volume with asignificant difference, p < 0.05 (as shown in Table 1).Identifying the TV locations, we observed that thesignificant differences, up to 12%, were located in theinternal mammary chain areas.This study confirms, using the MB algorithm, thatdosimetric parameters, derived from cDVH to lung andheart, will be increased (as shown in Table 2). The 2D γanalysis showed that the difference between plan 1 andplan 2 could reach up to ± 10%. Therefore, the tolerancelevel of 95% pixels with γ≤ 1 was not respected, showinga higher impact when using the density correction. Sincerespiratory gating is intended to reduce the dose to theheart and lungs, with the aim of reducing the risk ofcardiac mortality and lung toxicity, one should takeaccount of the alterations in dosimetry introduced bythis technique, to retain its advantages. Thus, any changefrom PBC to newer algorithms, i.e. CCC, AAA or AcurosXB, and even more so in the context of respiratorygating, should be very carefully undertaken.17-24
5. ConclusionThe most recent algorithms approximate lateral electrontransport accurately, either in breast tissue with adensity close to water, or lung with lower density. Whenusing the gating technique for breast cancer treatment
the lung density will be significantly decreased from0.27 to 0.16, p < 0.001. The MB method for 1Dheterogeneity correction overestimates the dose to theheart and lung. The physicist should be aware of thedifferences between the different dose calculationalgorithms and should be careful when changing fromolder algorithms such as PBC to newer algorithms, inorder to optimally protect the heart and lung.
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